Washington, D.C. - During a hearing of the House Judiciary Antitrust Subcommittee today, lawmakers announced the introduction of a new bipartisan legislative package that will enhance efforts to lower prescription drug costs by taking on anticompetitive practices employed by large pharmaceutical companies.
Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during a Subcommittee on Antitrust, Commercial, and Administrative Law hearing on "Treating the Problem: Addressing Anticompetitive Conduct and Consolidation in Health Care Markets:"
"The Judiciary Committee has a strong, bipartisan tradition of promoting competition in health care markets. We have done this vital work to make health care services-particularly prescription drugs-more affordable for patients.